Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status

Author:

Bertaut A.12,Mounier M.3,Desmoulins I.4,Guiu S.4,Beltjens F.5,Darut-Jouve A.6,Ponnelle T.7,Arnould L.5,Arveux P.12

Affiliation:

1. Côte d'Or Breast Cancer Registry; CGFL; Dijon France

2. EA 4184 Centre d'Epidémiologie des populations; University of Burgundy; Dijon France

3. Faculty of Medicine; Hemopathies Registry; Dijon France

4. Department of Medical Oncology; CGFL; Dijon France

5. Department of Pathology; CGFL; Dijon France

6. Oncology and Radiotherapy Centre; Dijon France

7. Pathology Centre; Dijon France

Publisher

Wiley

Subject

Oncology

Reference35 articles.

1. Breast cancer survival in the US and Europe: a CONCORD high-resolution study;Allemani;Int. J. Cancer,2013

2. Breast cancer with synchronous metastases: trends in survival during a 14-year period;Andre;Journal of Clinical Oncology,2004

3. Third consensus on medical treatment of metastatic breast cancer;Beslija;Annals of Oncology,2009

4. Update on triple-negative breast cancer: prognosis and management strategies;Brouckaert;International of Journal of Women's Health,2012

5. Does local surgery have a role in the management of stage IV breast cancer?;Carmichael;European Journal of Surgical Oncology,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3